Geriatric assessment and quality of life for 2 years in older patients with head and neck cancer

J Natl Cancer Inst. 2024 May 8;116(5):758-763. doi: 10.1093/jnci/djae027.

Abstract

Due to the location and toxicity of treatments, head and neck cancer (HNC) has a major impact on quality of life (QoL). Objective: to assess the effects of geriatric-assessment (GA)-driven interventions on QoL over 2 years in older adults with HNC.EGeSOR was a randomized study of HNC patients aged ≥65, receiving a pretreatment GA, a geriatric intervention and follow-up (intervention) or standard of care (control). The primary endpoint was QoL score using the European Organisation for Research and Treatment of Cancer's (EORTC QLQ-C30) and HNC (QLQ-HN35) QoL questionnaires over 24 months.In total, 475 patients were included (median age: 75.3; women: 31%; oral cancer: 44%). QoL scores improved over 24 months with various trajectories, without significant differences between the groups. A total of 74% of patients (interventional group) did not receive the complete intervention. Cancer characteristics, functional status, and risk of frailty were associated with change in the Global Health Status QoL score.There is a need to develop an alternative model of implementation such as patient-centered health-care pathways.

Trial registration: NCT02025062.

Publication types

  • Research Support, Non-U.S. Gov't
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Frailty / epidemiology
  • Geriatric Assessment*
  • Head and Neck Neoplasms* / psychology
  • Head and Neck Neoplasms* / therapy
  • Humans
  • Male
  • Middle Aged
  • Quality of Life*
  • Surveys and Questionnaires

Associated data

  • ClinicalTrials.gov/NCT02025062